Concepedia
Statistics
Publications
12
Citations
533
H-Index
Active since
2008
Affiliations
Queen Mary Hospital(Current)
University of Hong Kong
Chinese University of Hong Kong
Ruttonjee Hospital
Hilda Wong is an author at Queen Mary Hospital specializing in medicine, oncology, and hepatocellular carcinoma treatment.
Publications per year
2008–2014
The Significance of Early Alpha-Fetoprotein Level Changes in Predicting Clinical and Survival Benefits in Advanced Hepatocellular Carcinoma Patients Receiving Sorafenib
Thomas Yau, Tzy‐Jyun Yao, Pierre Chan et al. · The Oncologist · 2011 · 108 citations · Full text
Medicine, Oncology, Cancer Pharmacology +16
The use of single‐agent sorafenib in the treatment of advanced hepatocellular carcinoma patients with underlying Child‐Pugh B liver cirrhosis
Joanne Wing Yan Chiu, Yuen Fong Tang, Tzy‐Jyun Yao et al. · Cancer · 2012 · 69 citations · Full text
Medicine, Oncology, Pharmacotherapy +15
The Outcomes and Safety of Single-Agent Sorafenib in the Treatment of Elderly Patients with Advanced Hepatocellular Carcinoma (HCC)
Hilda Wong, Yuen Fong Tang, Tzy‐Jyun Yao et al. · The Oncologist · 2011 · 67 citations · Full text
Medicine, Oncology, Pharmacotherapy +13
Phase II study of bevacizumab and erlotinib in the treatment of advanced hepatocellular carcinoma patients with sorafenib-refractory disease
Thomas Yau, Hilda Wong, Pierre Chan et al. · Investigational New Drugs · 2012 · 66 citations · Full text
Medicine, Oncology, Pharmacotherapy +14
Targeted Therapy in the Management of Advanced Gastric Cancer: Are We Making Progress in the Era of Personalized Medicine?
Hilda Wong, Thomas Yau · The Oncologist · 2012 · 64 citations · Full text
Medicine, Molecular Medicine, Oncology +14
1–5 of 12